Expression and characterization of cysteine-modified variants of an amino-terminal fragment of bactericidal/permeability-increasing protein

被引:70
作者
Horwitz, AH
Leigh, SD
Abrahamson, S
GazzanoSantoro, H
Liu, PS
Williams, RE
Carroll, SF
Theofan, G
机构
[1] XOMA Corporation, Santa Monica, CA 90404
[2] XOMA Corporation, Berkeley, CA 94710
[3] Metra Biosystems, Inc., Mountain View, CA 94043
[4] Genentech, Inc., South San Francisco, CA 94080
[5] Immune Response Corporation, Carlsbad, CA 92008
关键词
D O I
10.1006/prep.1996.0071
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
rBPI(23) is a biologically active, recombinant N-terminal fragment of human bactericidal/permeability-increasing protein (BPI). While rBPI(23) is readily purified from culture supernatants of Chinese hamster ovary (CHO)-K1 transfectants, it is heterogeneous, consisting of monomer and disulfide-linked dimer, characteristics due presumably to the presence of three cysteines within the molecule. We have examined the role of these cysteines in rBPI(23) expression, function, and dimer formation by mutating their codons to alanine (C132A), serine (C135S), or alanine (C175A) and expressing analogues of N-terminal fragments (''variants'') lacking one, two, or all three cysteines in permanently transfected CHO-K1 cells. We also expressed a variant in which serine 18 was changed to cysteine (S18C), as found in both bovine and rabbit BPI. The C132A variant was readily secreted and purified as a homogeneous, stable monomeric protein species. The C135S and S18C variants were produced as mixtures of monomer and dimer; the C135S variant was poorly secreted, difficult to purify, and unstable on storage. In contrast, the C175A variant and those lacking any two or all three cysteines were expressed but not secreted. Purified rBPI(23) and the C132A and S18C variants had comparable bactericidal and lipopolysaccharide (LPS) binding activities and were similarly effective at neutralizing LPS-induced tumor necrosis factor synthesis by THP-I cells; the purified C135S variant lacked all activities. From these studies with CHO-K1 transfectants, we conclude that (i) cysteines 135 and 175 are both necessary for efficient secretion of a biologically active N-terminal BPI fragment, presumably through the formation of a disulfide bond, (ii) cysteine 132 is responsible for dimer formation, and (iii) only the C132A modification yields a stable, biologically active, N-terminal BPI fragment (designated rBPI(21)) that is free of dimeric species. (C) 1996 Academic Press, Inc.
引用
收藏
页码:28 / 40
页数:13
相关论文
共 39 条
[11]   HIGH-AFFINITY BINDING OF THE BACTERICIDAL PERMEABILITY-INCREASING PROTEIN AND A RECOMBINANT AMINO-TERMINAL FRAGMENT TO THE LIPID-A REGION OF LIPOPOLYSACCHARIDE [J].
GAZZANOSANTORO, H ;
PARENT, JB ;
GRINNA, L ;
HORWITZ, A ;
PARSONS, T ;
THEOFAN, G ;
ELSBACH, P ;
WEISS, J ;
CONLON, PJ .
INFECTION AND IMMUNITY, 1992, 60 (11) :4754-4761
[13]  
GRAY PW, 1989, J BIOL CHEM, V264, P9505
[14]   ENGINEERING HYBRID GENES WITHOUT THE USE OF RESTRICTION ENZYMES - GENE-SPLICING BY OVERLAP EXTENSION [J].
HORTON, RM ;
HUNT, HD ;
HO, SN ;
PULLEN, JK ;
PEASE, LR .
GENE, 1989, 77 (01) :61-68
[15]  
HORWITZ AH, 1995, BACTERICIDAL PERMEAB, P280
[16]   A RECOMBINANT AMINO-TERMINAL FRAGMENT OF BACTERICIDAL PERMEABILITY-INCREASING PROTEIN (RBPI23) INHIBITS SOLUBLE CD14-MEDIATED LIPOPOLYSACCHARIDE-INDUCED ENDOTHELIAL ADHERENCE FOR HUMAN NEUTROPHILS [J].
HUANG, K ;
CONLON, PJ ;
FISHWILD, DM .
SHOCK, 1994, 1 (02) :81-86
[17]  
JOCELYN PC, 1987, METHOD ENZYMOL, V143, P44
[18]   LIPOPOLYSACCHARIDE (LPS) PARTIAL STRUCTURES INHIBIT RESPONSES TO LPS IN A HUMAN MACROPHAGE CELL-LINE WITHOUT INHIBITING LPS UPTAKE BY A CD14-MEDIATED PATHWAY [J].
KITCHENS, RL ;
ULEVITCH, RJ ;
MUNFORD, RS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (02) :485-494
[19]   INTERACTION OF BIP WITH NEWLY SYNTHESIZED IMMUNOGLOBULIN LIGHT CHAIN MOLECULES - CYCLES OF SEQUENTIAL BINDING AND RELEASE [J].
KNITTLER, MR ;
HAAS, IG .
EMBO JOURNAL, 1992, 11 (04) :1573-1581
[20]   PROTECTIVE EFFECT OF A RECOMBINANT AMINO-TERMINAL FRAGMENT OF BACTERICIDAL PERMEABILITY-INCREASING PROTEIN IN EXPERIMENTAL ENDOTOXEMIA [J].
KOHN, FR ;
AMMONS, WS ;
HORWITZ, A ;
GRINNA, L ;
THEOFAN, G ;
WEICKMANN, J ;
KUNG, AHC .
JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (05) :1307-1310